Still wondering why US healthcare cost so high?

Video: Still wondering why US healthcare cost so high? For example prices for Ozempic and Wegovy, two European-made weight-loss drugs, expose US corrupted system ripping off our government & patients. 仍然想知道為什麼美國的醫療費用如此高? 例如Ozempic 和 Wegovy 這兩種歐洲製造的減肥藥的高價暴露了美國腐敗的體係正在敲詐美國政府和病人.

https://thehill.com/opinion/healthcare/4768725-drug-prices-pbm-rebates/
https://www.healthline.com/health-news/heres-how-much-more-ozempic-costs-in-the-u-s-compared-to-other-countries
https://www.cnbc.com/2024/03/27/novo-nordisk-ozempic-can-be-made-for-less-than-5-a-month-study.html
https://www.nytimes.com/2024/06/21/business/prescription-drug-costs-pbm.html
https://companiesmarketcap.com/usa/largest-american-companies-by-revenue/

Ozempic and Wegovy are successful weight loss drugs, manufactured by Norsk Nordisk, a Danish company. Both are highly effective against diabetes.

Critics complain about the pricing on these drugs in the United States, compared to peer countries. The monthly cost to US patients is over 10 times for patients in the UK, which is higher still than the burdens on patients in Australia and France.

The reason for the huge price disparities, however, is surprising, and sinister: it is primarily not driven by price-gouging drug companies, but by rent-seeking US health insurers. By creating a new sub-industry called Pharmacy Benefit Managers, and demanding "rebates" from drug companies hoping to sell in the US market, health insurers get around the profit caps established under the ObamaCare law, and enjoy billions of dollars in risk-free profits, with shocking cost increases borne by American patients, hospitals, and federal and state governments.

Ozempic 和 Wegovy 是成功的減肥藥，由丹麥公司 Norsk Nordisk 生產。 兩者都對糖尿病非常有效。

與其他國家相比，批評者抱怨這些藥物在美國的定價。 美國患者每個月的費用是英國患者的10倍以上，比澳洲和法國患者的負擔還要高。

然而，造成巨大價格差異的原因卻令人驚訝且險惡：這主要不是由哄抬價格的製藥公司推動的，而是由尋租的美國醫療保險公司推動的。 透過創建一個名為“藥品福利管理”的新子行業，並向希望在美國市場銷售的製藥公司要求“回扣”，健康保險公司繞過了奧巴馬醫改法規定的利潤上限，並享受了數十億美元的無風險收益.